Global Pen Needles Market, By Type (Standard Pen Needles, Safety Pen Needles), By Length (8MM, 5MM, 6MM, 4MM, 12MM, 10MM), By Therapy (Insulin Therapy, Growth Hormone Therapy, Glucagon-Like Peptide-1 Therapy, Other Therapies), By Mode Of Purchase (Retail, Non-Retail), By Region (North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle-East & Africa (MEA) Trend Analysis, Competitive Market Share & Forecast, 2017-2027

  • Published Date: August 2021
  • Report ID: BWC2120
  • Available Format: PDF
  • Page: 200

Report Overview

Pen needles are used for injecting medicine into the body through pen injectors. They are usually disposable and thus, have lesser chances of secondary infection or cross-contamination. In comparison to syringes and vials, they also cause less pain. Pen needles are also far more convenient to use and do not require the assistance of a physician.

The global pen needles market was worth USD 1.1 billion in 2020 and is further projected to reach USD 2.3 billion by the year 2027, growing at the CAGR of 10.4% in the forecast period. Due to the influence of factors such as the rising prevalence of chronic diseases like diabetes and the use of insulin injectors for glucose management in the body, along with improving healthcare services, technological advancements, and the use of pen needles for various therapies, the global pen needles market is gaining significant traction.

                                Pen Needles Market

Source: BlueWeave Consulting

Global Pen Needles Market- Overview

Pen needles are used for injecting medicine into the body through pen injectors. They are usually disposable and thus, have lesser chances of secondary infection or cross-contamination. In comparison to syringes and vials, they also cause less pain. Pen needles are also far more convenient to use and do not require the assistance of a physician. In simple words, pen needles are ideal for home health care settings. The vast majority of diabetic patients requiring frequent insulin injections inject pen needles on their own. That is why pen needles have a high demand among diabetic patients.

Global Pen Needles Market Forecast and Trends

Growth Drivers

Increasing Prevalence of Diabetes and Other Chronic Diseases

The growing prevalence of several chronic diseases like diabetes, cardiovascular diseases, etc., is one of the major driving factors for the growth of the global pen needles market. According to the National Health Council, the prevalence of chronic diseases in the United States is over 40%, with 133 million Americans suffering from them. It had been estimated that by 2020 there would be 157 million people with chronic illness, of which 81 million would have multiple conditions.

It is necessary for people with these chronic diseases to take medications at regular intervals to maintain the proper functioning of their bodies. Therefore, the adoption of pen needles is very prominent for drug injection, especially among the geriatric population. The increasing popularity of the pen needles among patients is especially due to the convenience it offers such as painless delivery of drugs, easy availability, easily disposability, etc., which in turn is favors the market growth.

Technological Advancements in The Pen Needles

Each individual has different needs for drugs and requires different concentrations of medication. Regular pen needles, on the other hand, inject the same amount of drug each time, which may not be optimal for treating chronic diseases. Concerns also surround needle anxiety in many patients. Therefore, market players are focusing on innovating their products and reducing the size of the pen needles to promote the adoption of these among a larger pool of patients. As a result, recent decades have seen a significant change in needle technology. For instance, Becton, Dickinson, and Company introduced a five-bevel needle tip that has a flatter and thinner surface to facilitate injections. Moreover, pen needles are now made with electro-polished needles for smoothness and fine and thin tips for ease of penetration, making them easier to handle and operate. The pen needles are also individually wrapped in plastic covers for further safety and lubricated for better glide and minimum friction.

Restraints

Confusion and Complications Regarding the Method Of Use

Several home health care patients rely on pen needles to inject their medications. After learning how to inject them from the caregivers, they often do so independently. The standard pen needle and the safety pen needle differ, however, in the type of medicine used for injection.There are high chances that patients are unaware of what medicine requires which type of pen needles. Due to this, confusion may arise regarding the correct usage of the pen needle, Moreover, non-compliance with the correct user manual of the pen needle may prevent the patient from injecting the medicine properly into their body. This acts as a huge restraining factor for the market of pen needles.

Impact of COVID-19 on Global Pen Needles Market

Patients suffering from chronic illnesses like diabetes, cardiovascular diseases, etc., are more prone to be getting infected with COVID-19. However, as the already surging cases of the COVID-19 virus put a huge burden on the healthcare facilities, the patients with chronic diseases were avoiding visiting healthcare facilities in the fear of contracting the virus. Because of this, the effective management of blood glucose levels in the body and proper medication became more crucial than ever. This resulted in the huge demand for pen needles for those under treatment at home as well as those suffering from both COVID-19 as well chronic diseases.

Global Pen Needles Market - By Type

Based on types, the global pen needle market is segmented into standard pen needles and safety pen needles. Standard pen needles accounted for the largest market share in 2020. They are increasingly used by patients who need a high dosage of medicine. A standard pen needle has both an outer and a removable inner cover whereas a safety pen needle only has the outer cover. However, the high risk associated with the use of standard needles may slow the demand. Since standard pen needles have an outer and inner needle cover. both the covers must be removed before injection.Without removing the inner cover of a standard pen needle, patients may be unable to receive medication, which may cause severe harm to the patient. Furthermore, safety pen needles, because of their advantages, are projected to witness a high CAGR during the forecast period.

Global Pen Needles Market - By Mode of Purchase

Based on the mode of purchase, the global pen needles market is segmented into retail and non-retail. The retail segment holds the largest market share. The easy availability of pen needles in the retail stores, as well as the discount offered on the purchase of products through this mode, are the driving factors for the retail segment. Moreover, the high number of diabetic patients injecting insulin on their own also influences the retail stores' demand for pen needles.

Global Pen Needles Market - Regional Insights

Geographically, the global pen needles market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle-East & Africa. North America dominated this market both in terms of demand and supply of pen needles in 2020. With the rising prevalence of diabetes and other chronic diseases, the demand for pen needles is surging very rapidly in the region. There are also plenty of supply options that satisfy the market demand because of a high concentration of industry players, such as Allison Medical, Inc., Becton Dickinson, and Company, etc. Europe is also gaining significant traction in the pen needles market with developed healthcare infrastructure and various government initiatives towards accelerating research and development in diabetic care.

Competitive Landscape

The leading market players in the global pen needles market are Owen Mumford Ltd., Becton Dickinson and Company, Novo Nordisk, Allison Medical, Inc., Ypsomed Holding AG, ArtsanaS.p.a, B. Braun Melsungen AG, HTL Strefa S.A., Terumo Corporation, Ultimed Inc., Vogt Medical Vertrieb, Nipro Corporation, Arkray, Ultimed, Hindustan Syringes And Medical Devices, Glucorx, Berpu Medical Technology, Advacare Pharma, Trividia Health, and other prominent players.

The key industry players essentially focus on innovating and advancing their products to gain a competitive edge in the market. They are also taking measures to grab a larger market share by strengthening their distribution channels and making their products more accessible, especially in the developing countries which hold great potential.

Recent Development

  1. In May 2021, Medtronic, an Irish medical device company, received the CE mark for its InPen smart insulin pen for multiple daily injections (MDI).
  2. In January 2021, Owen Mumford was appointed as the sole provider of the insulin pen needles to NHS Wales.The Owen safety pen needles, such as the AteriaSafecontrol safety pen needles, will now be available to all NHS Wales hospitals and community nurses.

Scope of the Report

Attributes

Details

Years Considered

Historical data – 2017-2020

Base Year – 2020

Forecast – 2021 – 2027

Facts Covered

Revenue in USD Million

Market Coverage

North America, Europe, the Asia-Pacific, Latin America, and the Middle East and Africa

Product Service/Segmentation

By Type, By Length, By Therapy, By Mode Of Purchase, By Region

Key Players

Owen Mumford Ltd., Becton Dickinson and Company, Novo Nordisk, Allison Medical, Inc., Ypsomed Holding AG, ArtsanaS.p.a, B. Braun Melsungen AG, HTL Strefa S.A., Terumo Corporation, Ultimed Inc., VOGT Medical Vertrieb, Nipro Corporation, Arkray, Ultimed, Hindustan Syringes And Medical Devices, Glucorx, Berpu Medical Technology, Advacare Pharma, Trividia Health, and other prominent players.

By Type

  • Standard Pen Needles
  • Safety Pen Needles

By Length

  • 4MM
  • 5MM
  • 6MM
  • 8MM
  • 10MM
  • 12MM

By Therapy

  • Insulin Therapy
  • Growth Hormone Therapy
  • Glucagon-Like Peptide-1 Therapy
  • Other Therapies

By Mode Of Purchase

  • Retail
  • Non-Retail

By Region

  • North America
  • Europe
  • Asia-Pacific (APAC)
  • Latin America (LATAM)

Ø Middle-East & Africa (MEA)

FAQs:

1. What is the current size of the global pen needles market?

Answer: The global pen needles market reached USD 1.1 billion in 2020.

2. What are the major factors driving the growth of the global pen needles market?

Answer: The major factors driving the growth of the global pen needles market are; increasing prevalence of diabetes and other chronic diseases and technological advancements in pen needles.

3. Who are the key players in the global pen needles market?

Answer: The key players in the global pen needles market are: Owen Mumford Ltd., Becton Dickinson and Company, Novo Nordisk, Allison Medical, Inc., Ypsomed Holding AG, ArtsanaS.p.a, B. Braun Melsungen AG, HTL Strefa S.A., Terumo Corporation, Ultimed Inc., Vogt Medical Vertrieb, Nipro Corporation, Arkray, Ultimed, Hindustan Syringes And Medical Devices, Glucorx, Berpu Medical Technology, Advacare Pharma, Trividia Health, and other prominent players.

4. Which therapy segment accounted for the largest share in the global pen needles market?

Answer: The insulin therapy segment accounted for the largest share in the global pen needles market.

5. Which region is at the highest growth rate in the global pen needles market?

Answer: North America has the largest share in the global pen needles market.